Revolve Wealth Partners LLC Invests $203,000 in CVS Health Corporation $CVS

Revolve Wealth Partners LLC bought a new position in CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The fund bought 2,938 shares of the pharmacy operator’s stock, valued at approximately $203,000.

Other institutional investors also recently bought and sold shares of the company. Bell Investment Advisors Inc grew its position in CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares during the last quarter. Roxbury Financial LLC lifted its stake in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the period. ORG Partners LLC lifted its stake in CVS Health by 418.9% during the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 377 shares during the period. Saudi Central Bank bought a new position in CVS Health during the 1st quarter valued at about $34,000. Finally, Livelsberger Financial Advisory bought a new position in CVS Health during the 2nd quarter valued at about $35,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Trading Up 1.6%

CVS Health stock opened at $79.67 on Wednesday. The firm has a 50 day moving average of $72.95 and a 200 day moving average of $67.83. The firm has a market capitalization of $101.05 billion, a price-to-earnings ratio of 22.25, a P/E/G ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $79.94. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last released its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s dividend payout ratio is currently 74.30%.

Insider Transactions at CVS Health

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 1.22% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CVS. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. The Goldman Sachs Group began coverage on shares of CVS Health in a research note on Tuesday. They set a “buy” rating and a $91.00 target price on the stock. Jefferies Financial Group upped their target price on shares of CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, June 30th. Weiss Ratings reiterated a “hold (c)” rating on shares of CVS Health in a research note on Tuesday. Finally, Mizuho increased their price objective on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and an average price target of $81.05.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.